SKYE vs MTCR
Comparison between Skye Bioscience Inc (SKYE, Company) and Metacrine Inc (MTCR, Company).
SKYE vs MTCR - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
SKYE
$25M
MTCR
$25M
Max Drawdown
SKYE
99.96%
Winner
MTCR
97.04%
Sharpe Ratio
SKYE
-0.29
Winner
MTCR
0.62
5Y Beta
SKYE
1.43
MTCR
N/A
Industry
SKYE
Biotechnology
MTCR
N/A
P/E Ratio
SKYE
-0.40
Winner
MTCR
-0.54
PEG Ratio
SKYE
-0.01
MTCR
N/A
5Y EPS CAGR
SKYE
-21.69%
MTCR
N/A
Debt to Equity
Winner
SKYE
0.00%
MTCR
37.20%
P/B Ratio
SKYE
N/A
MTCR
0.67
SKYE vs MTCR - Historical Returns
Returns include dividend reinvestment.
1M
SKYE
-9.05%
Winner
MTCR
+2.43%
3M
Winner
SKYE
+5.07%
MTCR
+2.41%
6M
SKYE
-29.26%
Winner
MTCR
+39.42%
1Y
SKYE
-66.95%
Winner
MTCR
+17.88%
5Y(CAGR)
SKYE
-55.92%
MTCR
N/A
10Y(CAGR)
SKYE
-40.74%
MTCR
N/A
Max(CAGR)
Winner
SKYE
-48.81%
MTCR
-66.40%
SKYE vs MTCR - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | SKYE | MTCR |
|---|---|---|
| 2026 | -19.46% | N/A |
| 2025 | -73.69% | N/A |
| 2024 | +4.04% | N/A |
| 2023 | -34.85% | +30.13% |
| 2022 | -70.55% | -36.01% |
| 2021 | +29.68% | -91.68% |
| 2020 | -72.41% | -33.16% |
| 2019 | -65.53% | N/A |
| 2018 | +116.22% | N/A |
| 2017 | -56.57% | N/A |
| 2016 | -52.81% | N/A |
| 2015 | -86.41% | N/A |
SKYE vs MTCR Drawdown Comparison
The maximum drawdown for SKYE was -99.96%, occurring on Mar 27, 2026. This drawdown has not yet recovered.
The maximum drawdown for MTCR was -97.04%, occurring on Oct 24, 2022. This drawdown has not yet recovered.
The current SKYE drawdown is -99.95%. The current MTCR drawdown is -95.06%.
| Rank | SKYE | MTCR |
|---|---|---|
| #1 | -99.96% Apr 7, 2015 - Mar 27, 2026 | -97.04% Sep 16, 2020 - Oct 24, 2022 |
Correlation
Correlation between SKYE and MTCR is 0.36 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.36
-101
Select Stocks to Compare
Popular: SKYE vs SPYMTCR vs SPY
More Comparisons
Compare with similar stocks